semaglutide losing inches not pounds Why is my GLP-1 medication working? Losing Inches but Not Weight

Consistent follow-up appointments play a significant role in the successful management of bipolar disorder with GLP-1 agonists

No vague reassurance

Participants treated with subcutaneous semaglutide 2.4 mg were initiated on a dose of 0.25 mg once weekly and the dose was escalated every 4 weeks to 0.5 mg, 1.0 mg and 1.7 mg, until the target dose of 2.4 mg was reached at week 16

In fact, more than 15% of patients taking the standard 0.5 mg dose reported Ozempic nausea, over 7% reported Ozempic stomach pain, and 8.5% reported Ozempic diarrhea

Once you have a better idea of your triggers, make a plan to address or avoid them